Antipsychotics for aggressive adolescents: barriers tobest practice

References

• Jensen PS, Bhatara V, Vitiello B, Hoagwood K, Feil M, Burke L Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. jAm. Acad. Child Adolesc. Psychiatry38, 557–565 (1999).
   PubMed Web of Science ®Google Scholar
• •Excellent review of psychopharmacological prescribing trends for youths highlighting the gaps between research and clinical practice.
   Google Scholar
• American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. jAm. Acad. Child Adolesc. Bychiatry36, 157–176 (1997).
   Google Scholar
• Pappadopulos E, Jensen PS, Schur SB etal 'Real world' atypical antipsychotic prescribing practices in public child and adolescent in-patient settings. Schizophr Bull 28(1), 111–121 (2002).
   PubMedGoogle Scholar
• •Demonstrates gaps between what physicians endorse as 'best practices' and what they actually do.
   Google Scholar
• Gutterman EM. Is diagnosis relevant in the hospitalization of potentially dangerous children and adolescents?' Am. Acad. Child Adolesc Psychiatry37, 1030–1037 (1998).
   PubMedGoogle Scholar
• Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RII. Psychopharmacology andaggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. jAm. Acad. Child Adolesc. PTchiatry41, May 15–20,253–261 (2002).
   Google Scholar
• Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL. A double-blind pilot study of risperidone in the treatment of conduct disorder. jAm. Acad. Child Adolesc Psychiatry39, 509–516 (2000).
   PubMed Web of Science ®Google Scholar
• Malone RP, Skeikh RM, Choudhury MS, Amighi AS, Amighi R Open Risperidone in pervasive developmental disorder: Efficacy and dyskinesias. Programs and Abstracts on New Research. Annual Meeting of the American Psychiatric Association, Washington, DC, USA, 258–259 (1999).
   Google Scholar
• Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML. Trends in antipsychotic use in children and adolescents: 1996 to 2000. J. Child Adolesc. PTchophamacol. 12,1219-1242 (2002).
   Google Scholar
• Connor DF, Ozbayrak KR, Harrison RJ, Melloni RII Jr. Prevalence and Patterns ofPsychotropic and Anticonvu1sant Medication Use in Children and Adolescents Referred to Residential Treatment. J: Child Adolesc. Psychopharmacol 8,27–38 (1998).
   Google Scholar
• Viten.° B, Behar D, Hunt J, Stoff D, Ricciuti A. Subtyping aggression in children and adolescents. J: Neuropsychiatry Clin. Neumsci. 2,189-192 (1990). iiAhsanuddin KM, Ivey JA, Schlotzhauer D, Hall K, Prosen H. Psychotropic medication prescription patterns in 100 hospitalized children and adolescents. jAm Acad. Child Adolesc. Psychiatry22, 361–364 (1983).
   Google Scholar
• Kaplan SL, Busner J. The use of pm and stat medication in three child psychiatric in-patient settings. PTchopharmacol Bull. 33,161–164 (1997).
   PubMedGoogle Scholar
• Zito JM, Craig TJ, Wanderling J. Pharmacoepidemiology of 30 child/ adolescent psychiatric patients. Pharmacoepidemiology3, 47–62 (1994).
   Google Scholar
• Woolston JL. Combined pharmacotherapy: Pitfalls of treatment. J. A117. Acad. Child Adolesc. PTchiatry38(11), 1455–1457 (1999).
   Google Scholar
• Miller AL, Craig CS. Combination antipsychotics: Pros, cons and questions. Schizophr Bull. 28(1), 105–109 (2002).
   Google Scholar
• Pappadopulos E, MacIntyre JC II, Crismon ML etal Treatment Recommendations for the use of Antipsychotics for Aggressive Youth (TRAAY): Part two — Recommendations for clinicians. J. Am. Acad. Child Adolesc. Psychiatry (In Press).
   Google Scholar
• •Presents the clinical-practice guidelines and rationale on the use of antipsychotic medications in aggressive youth.
   Google Scholar
• Schur SB, Sikich L, Findling R eta]. Treatments Recommendations for the use of Antipsychotics for Aggressive Youth (TRAAY) Part one: Review of the relevant literature. jAm. Acad. Child Adolesc. Psychiatry (In Press).
   Google Scholar
• •Thorough review of the evidence on pharmacological treatments for aggression with emphasis placed on the use of antipsychotics for aggression.
   Google Scholar
• Connor DE Aggression & Antisocial Behavior in Children and Adolescents: Research and Treatment. Guilford Press, New York, NY, USA (2002).
   Google Scholar
• Campbell M, Small AM, Green WH eta]. Behavioral efficacy of haloperidol and lithium carbonate: a comparison of hospitalized aggressive children with conduct disorder. Arch. Gen. 13yd-harry 41, 650–656 (1984).
   Google Scholar
• Greenhill LL, Solomon M, Pleak R, Ambrosini P Molindine hydrochloride of hospitalized children with conduct disorder.j Clin. Psychiatry 46, 20–25 (1986).
   Google Scholar
• Turgay A, Snyder R, Fisman S, Carrol A, Aman M. Risperidone versus placebo for severe conduct disorders in children with mental retardation. Scientific Proceedings of the 47th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, XVI: 118, New York, NY, USA, October 24–29, (2000).
   Google Scholar
• Aman MG, Findling, RL, Derivan A et al Risperidone versus placebo for severe conduct disorder in children with mental retardation. Presented at the 65th Annual Scientific Convention and Program of the Society of Biological Psychiatry, Chicago, IL, USA, May 11–13 (2000).
   Google Scholar
• Findling RL, Aman M, Derivan A. Long-term safety and efficacy of risperidone in children with significant conduct problems and borderline IQ or mental retardation. Scientific Proceedings of the 39th Annual Meeting of the American College of Neuropsychopharmacology, 224, San Juan, Puerto Rico, December 10–14 (2000).
   Google Scholar
• Gupta S. Risperidone-associated galactorrhea in a male teenager (letter). J. Am. Acad. Child Adolesc. Psychiatry 40, 504–505 (2001).
   PubMedGoogle Scholar
• Sikich L. Comparative use of olanzapine and risperidone in psychotic youth. Scientific Proceedings of the 154th Annual Meeting of the American Psychiatric Association, 326 (2001).
   Google Scholar
• Wirshing DA, Wirshing WC, Kysar L et al Novel antipsychotics: Comparison of weight gain liabilities. J. Clin. Psychiatry60, 358–363 (1999).
   PubMed Web of Science ®Google Scholar
• Lore C. Risperidone and withdrawal dyskinesia. jAm Acad. Child Adolesc. Psychiatry39, 941 (2000).
   PubMedGoogle Scholar
• Findling RL, Kusumakar V, Daneman D, Moshang M, DeSmedt G, Binder C. Prolactin levels in children after long-term treatment with risperidone. Poster presentation at the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, CA, USA, October 22–27 (2002).
   Google Scholar
• Kowatch RA, Suppes T, Gilfillan SK, Fuentes RM, Grannemann BD, Emslie GJ. Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: A clinical case series. J. Child Adolesc. Bychopharmacol 5,241–253 (1995).
   Web of Science ®Google Scholar
• Volavka J. The effects of clozapine on aggression and substance abuse in schizophrenic patients. j Clin. Psychiatry 60\(Suppl. 12), 43–46 (1999).
   Google Scholar
• Alvir J, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl. Med. 329,62-167 (1993).
   Google Scholar
• Ihde-Scholl T, Rolli ML, Jefferson JW. Clozapine and pulmonary embolus. Am. J. Pochiatry 158,499–500 (2001).
   PubMed Web of Science ®Google Scholar
• Remschmidt H, Hennighausen K, Clement HW, Heiser P, Schulz E. Atypical neuroleptics in child and adolescent psychiatry. Eur j Child Adolesc. Psychiatry 9\(Suppl. 1), 1/1-1/19 (2000).
   Google Scholar
• Henderson DC, Cagliero E, Gray C eta]. Clozapine, diabetes mellitus, weight gain and lipid abnormalities: A five-year naturalistic study. Am J. Psychiatry 157, 975–981 (2000).
   Google Scholar
• Allison DB, Mentore JL, Heo M et al Antipsychotic-induced weight gain: A comprehensive research synthesis. Am. J. PTchiatry156,1686–1696 (1999).
   PubMed Web of Science ®Google Scholar
• Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. Olanzapine treatment of children, adolescents and adults with pervasive developmental disorders: An open-label pilot study. J. Clin. Porhopharmacol 19,37–44 (1999).
   PubMed Web of Science ®Google Scholar
• Malone RP, Cater J, Sheikh R, Choudhury MS, Delaney MA. Olanzapine versus haloperidol in children with autistic disorder: An open pilot study. J. Am. Acad. Child Adolesc. Psychiatry 40,887–894 (2001).
   Google Scholar
• Selva IKA, Scott SM. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J. Pecliatr 138,936–938 (2001).
   Google Scholar
• McConville BJ, Arvanitis LA, Thyrum PT etal Pharmacokinetics, tolerability and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J. Clin. Psychiatry 61,252–260 (2000).
   PubMed Web of Science ®Google Scholar
• Sernyak MJ, Leslie DL, Alarcon RD, Losonczy ME, Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am. J. Psychiatry159,561–566 (2002).
   Google Scholar
• Sallee FR, Kurlan R, Goetz CG etal Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. jAm. Acad. Child Adolesc. Pochiatry 39,292–299 (2000).
   PubMed Web of Science ®Google Scholar
• Gury C, Canceil 0, Iaria P Antipsychotic drugs and cardiovascular safety: Current studies of prolonged QT interval and risk of ventricular arrhythmia. Encephak 26, 62–72 (2000).
   PubMedGoogle Scholar
• Kane JM, Carson WH, Saha AR et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with
   Google Scholar
• •• schizophrenia and schizoaffective disorder. Clin. Fiychiatry63(9), 763–771 (2002).
   Google Scholar
• Dawson S. Never mind solutions: What are the issues? Lessons on industrial technology transfer for quality in healthcare. Quality in Healthcare, 4,197–203 (1995).
   Google Scholar
• Grol R. Implementing guidelines in general practice care. Quality in Healthcam 1, 184–191 (1992).
   Google Scholar
• Walsh M. How nurses perceive barriers to research implementation. Nursing- Standard 11, 34–39 (1997).
   Google Scholar
• Cabana MD, Rand CS, Powe NR eta]. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAIVIA 282,1458–1465 (1999).
   Google Scholar
• ••Informative article on how physiciansperceive clinical practice guidelines.
   Google Scholar
• Torrey WC, Drake RE, Dixon L etal. Implementing evidence-based practices for persons with severe mental illnesses. Psychiatric Services52, 45–50 (2001).
   PubMed Web of Science ®Google Scholar
• •• The authors summarize perspectives on how to change and sustain best practices.
   Google Scholar
• Humphrey C, Barrow D. In the eye of the beholder: Problems of perception in designing a strategy to promote evidence-based clinical policy. J. Eval Clin. Prac. 6(2), 165–176 (2000).
   Google Scholar
• Feldman EL, Jaffe A, Galambos N, Robbins A, Kelly RB, Froom J. Clinical practice guidelines on depression: Awareness, attitudes and content knowledge among family physicians in New York. Arch. Fam. Med. 7,58–62 (1998).
   PubMedGoogle Scholar
• Davis DA, Taylor-Vaisey A. Translating guidelines into practice: A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. J. Can. Med Assoc. 157,408–416 (1997).
   PubMed Web of Science ®Google Scholar
• Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: Do conferences, workshops, rounds and other traditional continuing education activities change physician behavior or healthcare outcomes? JAMA, 282,867–874 (1999).
   Google Scholar
• Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance: The case of pediatric vaccine recommendations. Med. Care 34, 873–889 (1996).
   Google Scholar
• Butler CC, Rollnick S, Pill R, Maggs- Rapport M, Stott N. Understanding the culture of prescribing: Qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. Br. Med 317,637–642 (1998).
   Google Scholar
• Bandura A. Social Learning Theory Prentice Hall, Englewood Cliffs, NJ, USA (1977).
   Google Scholar
• Walker AE, Grimshaw JM, Armstrong EM. Salient beliefs and intentions to prescribe antibiotics for patients with a sore throat. Br.Health Ptychology6,347–360 (2001).
   Google Scholar
• Christakis DA, Rivara FR Pediatricians' awareness of and attitudes about four clinical practice guidelines. Pediatrics 101, 825–830 (1998).
   PubMed Web of Science ®Google Scholar
• Newton J, Knight E, Woolhead G. General practitioners and clinical guidelines: A survey of knowledge, use and beliefs. BE J. Gen. Pract. 46,513-517 (1996).
   Google Scholar
• Bernard P, Littlejohn R. The use of 'as- required' medication on an adolescent psychiatric unit. Clin. Child Psychology FiychMtry5,258–266 (2000).
   Google Scholar
• Patel VL, Groen GJ, Norman GR. Reasoning and instruction in medical curricula. Cognition Instruct. 10,335–378 (1993).
   Web of Science ®Google Scholar
• Patel VL, Arocha JF, Diermeier M, How J, Mottur-Pilson C. Cognitive psychological studies of representation and use of clinical practice guidelines. Int. J. Med. Inf 63, 147–167 (2001).
   Google Scholar
• Patel VL, Glaser R, Arocha JE Cognition and expertise: acquisition of medical competence. Clin. Invest. Med. 256–60 (2000).
   Google Scholar
• Bastiaens L. Compliance with pharmacotherapy in adolescents: Effects of patients' and parents' knowledge and attitudes towards treatment. J. Child Adolesc. Ptychopharmacology5,39–48 (1995).
   Web of Science ®Google Scholar
• •Reveals insights into how parental attitudes may impede the effectiveness of pharmacological treatments.
   Google Scholar
• Buston K. Adolescents with mental health problems: What do they say about health services? Adolesc. 25,231–242 (2002).
   Google Scholar
• Glanz D, Lewis FM, Rimer BK. Health Behavior and Health Education: Theory Research and Practice. Jossey-Bass Publishers, San Francisco, CA, USA (1990).
   Google Scholar
• Kelly GR, Mamon JA, Scott JE. Utilizing the health belief model in examining medication compliance. Soc. Sci. Med. 25, 1205–1211 (1987).
   Google Scholar
• •Demonstrates how interpersonal and cognitive theories can enhance our understanding of medication nonadherence.
   Google Scholar
• Fishbein M, Ajzen I. Belief, Attitude, Intention and Behavior: An Introduction to Theoty and Researrh. Addison-Wesley, Reading, MA, USA (1975).
   Google Scholar
• Fishbein M. Developing effective behavior change interventions: Some lessons learned from behavioral research. In: Reviewing the Behavioral Science Knowledge Base on Technology Transfer Backer TE, Dabid SL, Saucy G (Eds), NIDA, Rockville, MD, USA (1995). 'How to' paper on developing effective behavior change strategies based on the Theory of Planned Behavior.
   Google Scholar
• Corrigan PW. Adherence to antipsychotic medications and health behavior theories. J. Mental Health 11, 243–254 (2002).
   Google Scholar
• Spear HJ, Kulbok PA. Adolescent health behaviors and related factors: A review. Public Health NUIN. 18(2), 82–93 (2001).
   Google Scholar
• Mildowitz DJ, Goldstein MJ. Bipolar Disorder' A Family-Focused Treatment Approach. The Guilford Press, New York, NY, USA (1997).
   Google Scholar
• Adams SG, Howe JT. Predicting medication compliance in a psychotic population. J. Nerv. Ment. Dis. 181,558–560 (1993).
   PubMed Web of Science ®Google Scholar
• Budd RJ, Hughes ICT, Smith JA. Health beliefs and compliance with antipsychotic medication. BE J. Clin. Ptychol 35,393–397 (1996).
   Google Scholar
• Connelly CE. Compliance with out-patient lithium therapy. Perspect. Ptychiatr Cam 22, 44–50 (1984).
   PubMedGoogle Scholar
• Pan PC, Tantam D. Clinical characteristics, health beliefs and compliance with maintenance treatment: A comparison between regular and irregular attenders at a depot clinic. Acta Ptychiatr Scand 79,564–570 (1989).
   PubMed Web of Science ®Google Scholar
• Rappaport N, Chubinsky R The meaning of psychotropic medications for children, adolescents and their families. J. Am. Acad. Child Adolesc. Psychiatry 39,1198–1200 (2000).
   PubMed Web of Science ®Google Scholar
• Hack S, Chow B. Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance. J. Child Adolesc. PTchopharmacol 11,59–67 (2001).
   PubMed Web of Science ®Google Scholar
• Cramer JA, Rosenbeck R. Compliance with medication regimens for psychiatric and medical disorders. Psychiatric Services 49, 196–210 (1998).
   PubMed Web of Science ®Google Scholar
• Weiden PJ, Olfson M, Essock S. Medication noncompliance in schizophrenia: Effects on mental health service policy. In: Treatment Compliance and the Therapeutic Alliance: Chronic Mental illness (Volume 5). Blackwell B (Ed.), Harwood Academic Publishers, NY, USA, 35–60 (1997).
   Google Scholar
• Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr Bull. 17,111–132 (1991).
   Google Scholar
• Amador XF, Flaum M, Andreasen NC et al Awareness of illness in schizophrenia and schizoaffective and mood disorders. Atrh. Gen. Psychiatry51, 826–836 (1994).
   PubMed Web of Science ®Google Scholar
• Ruscher S, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatric Seridces48, 82–85 (1997).
   PubMed Web of Science ®Google Scholar
• Wilson LJ, Jennings JN. Parents' acceptability of alternative treatments for attention-deficit hyperactivity disorder. J. Attention Disorders 1 (2), 114–121 (1996) .
   Google Scholar
• Pappadopulos E, Siennick S, Schur S, Gentry L. Enhancing adherence to best practice guidelines. Report on Emotional and Behavioial Dirac/en. in Youth 2,61–68 (2002).
   Google Scholar
• Mohr WK. Rethinking professional attitudes in mental health settings. Qualitative Health Res. 10,595–611 (2000).
   PubMedGoogle Scholar
• Cockburn J, Pitt S. Prescribing behavior in clinical practice: Patients' expectations and doctors' perceptions of patients' expectations: A questionnaire study. BE Med. 315,520–523 (1997).
   PubMed Web of Science ®Google Scholar
• •Shows how consumer expectations can drive treatment.
   Google Scholar
• Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: Friends or foes. Harvard Rev. Rychiatry9, 223–233 (2001).
   PubMed Web of Science ®Google Scholar
• •Demonstrates how parents' core beliefs about psychopharmacological treatments are idiosyncratic and lead them to selectively apply their physicians' prescribing recommendations in a manner that suits their own notions about what will be effective.
   Google Scholar
• Shon SD, Toprac MG, Crismon ML, Rush AJ. Strategies for implementing psychiatric medication algorithms in the public sector. Prac. Psych. Behav. Health 5,32–36 (1999).
   Google Scholar
• Jenson CE, Green RG, Singh NN, Best AM, Ellis CR. Parental attributions of the causes of their children's behavior. I Child Family Studies 7 (2), 205–215 (1998).
   Google Scholar
• Motlov6. L. Psychoeducation as an indispensable complement to pharmacotherapy in schizophrenia. Pharmacopsychiatry33(Suppl.), 47–48 (2000).
   Google Scholar
• Weiss M, Jain U, Garland J. Clinical suggestions for management of stimulant treatment in adolescents. Can. J. Rychiatry 45,717–723 (2000).
   Google Scholar
• Golin C, Isasi F, Bontempi JB, Eng E. Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina. AIDS Education and Prevention 14 (4), 318–329 (2002) .
   PubMed Web of Science ®Google Scholar
• Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am.Psychiatry 159,1653–1664(2002).
   PubMed Web of Science ®Google Scholar
• Fleming ME. Strategies to increase alcohol screening in healthcare settings. Alcohol Health Res. WorIc121, 340–347 (1997).
   Google Scholar
• www.mhmr.state.tx.us/centraloffice/ medicaldirector/timasczman.pdf Affiliations
   Google Scholar